Search research articles
Contact Us
Filters
Showing results (41-50 of 150) with videos related to
Page
of 15
Sort By:
Critical Reviews in Oncology/Hematology
|
July 6, 2025
Bridging the Gap: the role of MDM2 inhibition in overcoming treatment resistance in breast cancer
Giuseppe Di Grazia, Chiara Conti, Sabrina Nucera, et al.
Frontiers in Oncology
|
August 30, 2024
REThinking the role of the RET oncogene in breast cancer
Giuseppe Di Grazia, Chiara Conti, Sabrina Nucera, et al.
International Journal of Molecular Sciences
|
June 22, 2017
New Insights in Thyroid Cancer and p53 Family Proteins
Livia Manzella, Stefania Stella, Maria Stella Pennisi, et al.
Medicina (Kaunas, Lithuania)
|
October 28, 2023
More Than Meets the Eye: A Case of Breast Cancer Switching from Being Luminal-Androgen-Receptor-Positive to Being Hormone-Receptor-Positive
Federica Martorana, Giuseppe Di Grazia, Giovanni Nunzio Rosano, et al.
Molecular and Cellular Endocrinology
|
August 8, 2022
Comparative proteomic analysis of insulin receptor isoform A and B signaling
Roberta Malaguarnera, Caterina Gabriele, Gianluca Santamaria, et al.
Thyroid : Official Journal of the American Thyroid Association
|
December 28, 2019
Concentration of Metals and Trace Elements in the Normal Human and Rat Thyroid: Comparison with Muscle and Adipose Tissue and Volcanic Versus Control Areas
Pasqualino Malandrino, Marco Russo, Anna Ronchi, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners
|
November 29, 2023
A review and metanalysis of metronomic oral single-agent cyclophosphamide for treating advanced ovarian carcinoma in the era of precision medicine
Federica Martorana, Giuseppina Scandurra, Maria Rosaria Valerio, et al.
Endocrine-Related Cancer
|
December 3, 2005
The p53-homologue p63 may promote thyroid cancer progression
Roberta Malaguarnera, Angelo Mandarino, Emanuela Mazzon, et al.
The Journal of Clinical Endocrinology and Metabolism
|
April 6, 2013
Thyroid cancer cell resistance to gefitinib depends on the constitutive oncogenic activation of the ERK pathway
Francesco Frasca, Veronica Vella, Maria Luisa Nicolosi, et al.
Oncology Letters
|
August 30, 2022
Immunoexpression of p62/SQSTM1/Sequestosome-1 in human primary and recurrent IDH1/2 wild-type glioblastoma: A pilot study
Antonio Ieni, Cristina Pizzimenti, Giuseppe Broggi, et al.
Page
of 15
Search research articles
Search
Showing results (41-50 of 150) with videos related to
Sort By:
Page
of 15
Critical Reviews in Oncology/Hematology
|
July 6, 2025
Bridging the Gap: the role of MDM2 inhibition in overcoming treatment resistance in breast cancer
Giuseppe Di Grazia, Chiara Conti, Sabrina Nucera, et al.
Frontiers in Oncology
|
August 30, 2024
REThinking the role of the RET oncogene in breast cancer
Giuseppe Di Grazia, Chiara Conti, Sabrina Nucera, et al.
International Journal of Molecular Sciences
|
June 22, 2017
New Insights in Thyroid Cancer and p53 Family Proteins
Livia Manzella, Stefania Stella, Maria Stella Pennisi, et al.
Medicina (Kaunas, Lithuania)
|
October 28, 2023
More Than Meets the Eye: A Case of Breast Cancer Switching from Being Luminal-Androgen-Receptor-Positive to Being Hormone-Receptor-Positive
Federica Martorana, Giuseppe Di Grazia, Giovanni Nunzio Rosano, et al.
Molecular and Cellular Endocrinology
|
August 8, 2022
Comparative proteomic analysis of insulin receptor isoform A and B signaling
Roberta Malaguarnera, Caterina Gabriele, Gianluca Santamaria, et al.
Thyroid : Official Journal of the American Thyroid Association
|
December 28, 2019
Concentration of Metals and Trace Elements in the Normal Human and Rat Thyroid: Comparison with Muscle and Adipose Tissue and Volcanic Versus Control Areas
Pasqualino Malandrino, Marco Russo, Anna Ronchi, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners
|
November 29, 2023
A review and metanalysis of metronomic oral single-agent cyclophosphamide for treating advanced ovarian carcinoma in the era of precision medicine
Federica Martorana, Giuseppina Scandurra, Maria Rosaria Valerio, et al.
Endocrine-Related Cancer
|
December 3, 2005
The p53-homologue p63 may promote thyroid cancer progression
Roberta Malaguarnera, Angelo Mandarino, Emanuela Mazzon, et al.
The Journal of Clinical Endocrinology and Metabolism
|
April 6, 2013
Thyroid cancer cell resistance to gefitinib depends on the constitutive oncogenic activation of the ERK pathway
Francesco Frasca, Veronica Vella, Maria Luisa Nicolosi, et al.
Oncology Letters
|
August 30, 2022
Immunoexpression of p62/SQSTM1/Sequestosome-1 in human primary and recurrent IDH1/2 wild-type glioblastoma: A pilot study
Antonio Ieni, Cristina Pizzimenti, Giuseppe Broggi, et al.
Page
of 15